These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 9832261)

  • 1. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD; Petri WA
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards development of a vaccine for amebiasis.
    Stanley SL
    Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
    Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
    Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
    Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future for vaccine development against Entamoeba histolytica.
    Quach J; St-Pierre J; Chadee K
    Hum Vaccin Immunother; 2014; 10(6):1514-21. PubMed ID: 24504133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.
    Stanley SL; Blanchard JL; Johnson N; Foster L; Kunz-Jenkins C; Zhang T; Tian K; Cogswell FB
    Vaccine; 1995 Jul; 13(10):947-51. PubMed ID: 7483769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.
    Zhang T; Cieslak PR; Stanley SL
    Infect Immun; 1994 Apr; 62(4):1166-70. PubMed ID: 8132322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis.
    Lotter H; Zhang T; Seydel KB; Stanley SL; Tannich E
    J Exp Med; 1997 May; 185(10):1793-801. PubMed ID: 9151705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Protective Mechanisms to Intestinal Amebiasis.
    Uddin MJ; Leslie JL; Petri WA
    Trends Parasitol; 2021 Feb; 37(2):165-175. PubMed ID: 33502317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
    Miller-Sims VC; Petri WA
    Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI; Shain DC; Kelsall BL
    Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amebiasis: host-pathogen biology.
    Sepúlveda B
    Rev Infect Dis; 1982; 4(6):1247-53. PubMed ID: 6296964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica.
    Mann BJ; Burkholder BV; Lockhart LA
    Vaccine; 1997; 15(6-7):659-63. PubMed ID: 9178467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.
    Stanley SL; Reed SL
    Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1049-54. PubMed ID: 11352795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
    Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
    Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing a Multi-Component Intranasal
    Abhyankar MM; Orr MT; Kinsey R; Sivananthan S; Nafziger AJ; Oakland DN; Young MK; Farr L; Uddin MJ; Leslie JL; Burgess SL; Liang H; De Lima I; Larson E; Guderian JA; Lin S; Kahn A; Ghosh P; Reed S; Tomai MA; Pedersen K; Petri WA; Fox CB
    Front Immunol; 2021; 12():683157. PubMed ID: 34248966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the PE
    Martínez-Hernández SL; Becerra-González VM; Muñoz-Ortega MH; Loera-Muro VM; Ávila-Blanco ME; Medina-Rosales MN; Ventura-Juárez J
    J Immunol Res; 2021; 2021():6697900. PubMed ID: 33824880
    [No Abstract]   [Full Text] [Related]  

  • 18. Entamoeba histolytica: from adherence to enteropathy.
    Ravdin JI
    J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of an
    Abhyankar MM; Xu F; Chavez D; Goodroe A; Mendoza E; Chen C; Singh DK; Varnador F; Sivananthan SJ; Kinsey R; Lykins WR; Murphy BM; Martin AR; Tomai MA; Ghosal S; Casper C; Pedersen K; Petri WA; Fox CB
    Hum Vaccin Immunother; 2024 Dec; 20(1):2374147. PubMed ID: 39090779
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
    Ivory CP; Chadee K
    Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.